Document is current

In Vivo Antitumor Activity of a Novel Orally Bioavailable Ifosfamide Nanostructured Lipid Carrier Against Dalton’s Ascitic Lymphoma

Crossref DOI link: https://doi.org/10.1007/s12247-014-9187-0

Published Online: 2014-05-01

Published Print: 2014-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy